Compare Calistoga Pharmaceuticals vs Intercept Pharmaceuticals
Customers evaluate the quality of Calistoga Pharmaceuticals's products using the following success metrics.
Overview
Calistoga Pharmaceuticals is 18 yrs old and is based in United States.
Calistoga Pharmaceuticals is a biopharmaceutical company developing multiple compounds selectively targeting the PI3K pathway, a pathway known to be involved in certain cancers and inflammatory diseases. In February 2011, Calistoga Pharmaceuticals was acquired by Gilead Sciences. The valuation of Calistoga Pharmaceuticals was $375 million.
Intercept Pharmaceuticals is 22 yrs old and is based in United States.
Intercept Pharmaceuticals engages in the development and commercialization of novel therapeutics in the healthcare sector. Its offerings include the development and delivery of medicines for conditions such as primary biliary cholangitis and severe alcohol-associated hepatitis. The company primarily serves the healthcare industry, with a particular emphasis on liver health. It was founded in 2002 and is based in Morristown, New Jersey.
Demo Video
Leadership
Neill Giese (Chief Security Officer)
Mark Pruzanski (Founder)
Investors
Gilead Sciences, Alta Partners
Interstellar Acquisition, Genextra
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Calistoga Pharmaceuticals has not claimed their profile.
Work for Calistoga Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Calistoga Pharmaceuticals?
Claim your profile now.
Information not available because Intercept Pharmaceuticals has not claimed their profile.
Work for Intercept Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Intercept Pharmaceuticals?
Claim your profile now.